Trk receptor tyrosine kinases: a bridge between cancer and neural development
- PMID: 11431098
- DOI: 10.1016/s0304-3835(01)00530-4
Trk receptor tyrosine kinases: a bridge between cancer and neural development
Abstract
The proto-oncogene Trks encode the high-affinity receptor tyrosine kinases for neurotrophins of a nerve growth factor (NGF) family. The Trk signals spatiotemporally regulate neural development and maintenance of neural network. However, Trk was originally cloned as an oncogene fused with the tropomyosin gene in the extracellular domain. Accumulating evidence has demonstrated that the rearranged Trk oncogene is often observed in non-neuronal neoplasms such as colon and papillary thyroid cancers, while the signals through the receptors encoded by the proto-oncogene Trks regulate growth, differentiation and apoptosis of the tumors with neuronal origin such as neuroblastoma and medulloblastoma. The intracellular Trk signaling pathway is also different depending on the Trk family receptors, cell types and the grade of transformation. Furthermore, developmentally programmed cell death of neuron, which is largely regulated by neurotrophin signaling, is at least in part controlled by tumor suppressors p53 and p73 as well as their antagonist DeltaNp73. Thus, the Trks and their downstream signaling function in both ontogenesis and oncogenesis. In this short review, the dynamic role of the Trk family receptors signaling in neural development, neurogenic tumors and other cancers will be discussed.
Similar articles
-
Neurotrophin receptors expression and JNK pathway activation in human astrocytomas.BMC Cancer. 2007 Oct 31;7:202. doi: 10.1186/1471-2407-7-202. BMC Cancer. 2007. PMID: 17971243 Free PMC article.
-
Neurotrophin effects on neuroblastoma cells: correlation with trk and p75NTR expression and influence of Trk receptor bodies.J Neurooncol. 2004 Jan;66(1-2):101-10. doi: 10.1023/b:neon.0000013492.37426.0c. J Neurooncol. 2004. PMID: 15015775
-
Intracellular LINGO-1 negatively regulates Trk neurotrophin receptor signaling.Mol Cell Neurosci. 2016 Jan;70:1-10. doi: 10.1016/j.mcn.2015.11.002. Epub 2015 Nov 3. Mol Cell Neurosci. 2016. PMID: 26546150 Free PMC article.
-
The trk family of oncogenes and neurotrophin receptors.Princess Takamatsu Symp. 1991;22:153-70. Princess Takamatsu Symp. 1991. PMID: 1844238 Review.
-
The Trk family of neurotrophin receptors.J Neurobiol. 1994 Nov;25(11):1386-403. doi: 10.1002/neu.480251107. J Neurobiol. 1994. PMID: 7852993 Review.
Cited by
-
Selective type II TRK inhibitors overcome xDFG mutation mediated acquired resistance to the second-generation inhibitors selitrectinib and repotrectinib.Acta Pharm Sin B. 2024 Feb;14(2):517-532. doi: 10.1016/j.apsb.2023.11.010. Epub 2023 Nov 8. Acta Pharm Sin B. 2024. PMID: 38322338 Free PMC article. Review.
-
Developing a novel neutralizing monoclonal antibody against TrkB.3 Biotech. 2024 Oct;14(10):221. doi: 10.1007/s13205-024-04063-x. Epub 2024 Sep 5. 3 Biotech. 2024. PMID: 39247456
-
TrkB receptor signalling: implications in neurodegenerative, psychiatric and proliferative disorders.Int J Mol Sci. 2013 May 13;14(5):10122-42. doi: 10.3390/ijms140510122. Int J Mol Sci. 2013. PMID: 23670594 Free PMC article. Review.
-
Twist2 promotes kidney cancer cell proliferation and invasion by regulating ITGA6 and CD44 expression in the ECM-receptor interaction pathway.Onco Targets Ther. 2016 Mar 29;9:1801-12. doi: 10.2147/OTT.S96535. eCollection 2016. Onco Targets Ther. 2016. PMID: 27099513 Free PMC article.
-
NTRK fusion in Japanese colorectal adenocarcinomas.Sci Rep. 2021 Mar 11;11(1):5635. doi: 10.1038/s41598-021-85075-y. Sci Rep. 2021. PMID: 33707574 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous